Erratum: Intensive glucose control and risk of cancer in patients with type 2 diabetes (Diabetologia DOI: 10.1007/s00125-011-2104-x);Intensive glucose control and risk of cancer in patients with type 2 diabetes

Diabetologia

Volumn 54, Issue 7, 2011, Pages 1608-1614

  Stefansdottir, G ^a,b   Zoungas, S ^c,d   Chalmers, J ^c   Kengne, A P ^c   Knol, M J ^a,b   Leufkens, H G M ^b   Patel, A ^c   Woodward, M ^c   Grobbee, D E ^a   De Bruin, M L ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Cancer; Glucose control; Incidence; Type 2 diabetes

Indexed keywords

GLICLAZIDE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DRUG USE; FEMALE; FOLLOW UP; GYNECOLOGIC CANCER; HUMAN; LIP CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALE GENITAL TRACT CANCER; MOUTH CANCER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS CANCER; PHARYNX CANCER; PRIORITY JOURNAL; RESPIRATORY TRACT CANCER; SOLID TUMOR;

EID: 79959761675     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-013-2980-3     Document Type: Erratum

References (32)

1. P Vigneri F Frasca L Sciacca G Pandini R Vigneri 2009 Diabetes and cancer Endocr Relat Cancer 16 1103 1123 19620249 10.1677/ERC-09-0087 1:CAS:528:DC%2BC3cXhtFOgu7w%3D
2. E Giovannucci D Michaud 2007 The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas Gastroenterology 132 2208 2225 17498513 10.1053/j.gastro.2007.03.050 1:CAS:528: DC%2BD2sXmsVyns7Y%3D (Pubitemid 46693749)
3. AA Samani S Yakar D LeRoith P Brodt 2007 The role of the IGF system in cancer growth and metastasis: overview and recent insights Endocr Rev 28 20 47 16931767 10.1210/er.2006-0001 1:CAS:528:DC%2BD2sXjtFCgsrg%3D (Pubitemid 46220849)
4. EK Lam GD Batty RR Huxley, et al. 2010 Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region Ann Oncol 10.1093/annonc/mdq1405
5. T Stocks K Rapp T Bjorge, et al. 2009 Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts PLoS Med 6 e1000201 20027213 10.1371/journal.pmed. 1000201
6. P Stattin O Bjor P Ferrari, et al. 2007 Prospective study of hyperglycemia and cancer risk Diabetes Care 30 561 567 17327321 10.2337/dc06-0922 (Pubitemid 46354334)
7. X Yang GT Ko WY So, et al. 2010 Associations of hyperglycemia and insulin usage with the risk of cancer in type 2 diabetes: the Hong Kong Diabetes Registry Diabetes 59 1254 1260 20185812 10.2337/db09-1371 1:CAS:528: DC%2BC3cXmtFegtrs%3D
8. K Rapp J Schroeder J Klenk, et al. 2006 Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria Diabetologia 49 945 952 16557372 10.1007/s00125-006-0207-6 1:CAS:528:DC%2BD28XjvFWrtLg%3D
9. SH Saydah EA Platz N Rifai MN Pollak FL Brancati KJ Helzlsouer 2003 Association of markers of insulin and glucose control with subsequent colorectal cancer risk Cancer Epidemiol Biomarkers Prev 12 412 418 12750235 1:CAS:528:DC%2BD3sXjsleitLo%3D (Pubitemid 36578478)
10. JM Jonasson R Ljung M Talback B Haglund S Gudbjornsdottir G Steineck 2009 Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 1745 1754 19588120 10.1007/s00125-009-1444-2 1:STN:280:DC%2BD1MrktlygtQ%3D%3D
11. HM Colhoun SDRN Epidemiology Group 2009 Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 1755 1765 19603149 10.1007/s00125-009-1453-1 1:STN:280:DC%2BD1Mrktl2kuw%3D%3D Erratum 52: 2469
12. SL Bowker SR Majumdar P Veugelers JA Johnson 2006 Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin Diabetes Care 29 254 258 16443869 10.2337/diacare.29.02.06.dc05-1558 (Pubitemid 44106500)
13. CJ Currie CD Poole EA Gale 2009 The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 1766 1777 19572116 10.1007/s00125-009-1440-6 1:CAS:528:DC%2BD1MXpsFyrsLo%3D
14. SL Bowker Y Yasui P Veugelers JA Johnson 2010 Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure Diabetologia 53 1631 1637 20407744 10.1007/s00125-010-1750-8 1:CAS:528:DC%2BC3cXotVKgs7g%3D
15. U Smith EA Gale 2009 Does diabetes therapy influence the risk of cancer? Diabetologia 52 1699 1708 19597799 10.1007/s00125-009-1441-5 1:STN:280:DC%2BD1Mrktl2mtQ%3D%3D
16. HC Gerstein 2010 Does insulin therapy promote, reduce, or have a neutral effect on cancers? JAMA 303 446 447 20124540 10.1001/jama.2010.60 1:CAS:528:DC%2BC3cXhs1GgtLo%3D
17. JM Nagel U Mansmann K Wegscheider J Rohmel 2010 Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine Diabetologia 53 206 208 19774358 10.1007/s00125-009-1535-0 1:STN:280:DC%2BC3c%2FjsFyiug%3D%3D
18. SJ Pocock L Smeeth 2009 Insulin glargine and malignancy: an unwarranted alarm Lancet 374 511 513 19616841 10.1016/S0140-6736(09)61307-6
19. SK Garg JS Skyler 2009 Insulin glargine and cancer-an unsubstantiated allegation Diabetes Technol Ther 11 473 476 19591544 10.1089/dia.2009.1705 1:CAS:528:DC%2BD1MXhtVGjtbvK
20. A Patel S MacMahon J Chalmers, et al. 2007 Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 829 840 17765963 10.1016/S0140-6736(07)61303-8 1:CAS:528:DC%2BD2sXhtVWjs7zO (Pubitemid 47362321)
21. A Patel S MacMahon J Chalmers, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 18539916 10.1056/NEJMicm066227 1:CAS:528:DC%2BD1cXnt1yht7s%3D (Pubitemid 351214289)
22. The ADVANCE Collaborative Group 2001 Study rationale and design of ADVANCE: action in diabetes and vascular disease-preterax and diamicron MR controlled evaluation Diabetologia 44 1118 1120 10.1007/s001250100612 (Pubitemid 32835503)
23. G Chodick AD Heymann L Rosenmann, et al. 2010 Diabetes and risk of incident cancer: a large population-based cohort study in Israel Cancer Causes Control 21 879 887 20148361 10.1007/s10552-010-9515-8
24. M Inoue M Iwasaki T Otani S Sasazuki M Noda S Tsugane 2006 Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan Arch Intern Med 166 1871 1877 17000944 10.1001/archinte.166.17.1871 (Pubitemid 44455170)
25. R Kaaks P Toniolo A Akhmedkhanov, et al. 2000 Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women J Natl Cancer Inst 92 1592 1600 11018095 10.1093/jnci/92.19.1592 1:CAS:528:DC%2BD3cXnsVKitrw%3D
26. P Toniolo PF Bruning A Akhmedkhanov, et al. 2000 Serum insulin-like growth factor-I and breast cancer Int J Cancer 88 828 832 11072255 10.1002/1097-0215(20001201)88:5<828::AID-IJC22>3.0.CO;2-8 1:CAS:528:DC%2BD3cXot1Sqtb8%3D
27. F Frasca G Pandini L Sciacca, et al. 2008 The role of insulin receptors and IGF-I receptors in cancer and other diseases Arch Physiol Biochem 114 23 37 18465356 10.1080/13813450801969715 1:CAS:528:DC%2BD1cXotlKls7s%3D (Pubitemid 351998752)
28. M Okumura M Yamamoto H Sakuma, et al. 2002 Leptin and high glucose stimulate cell proliferation in MCF-7 human breast cancer cells: reciprocal involvement of PKC-alpha and PPAR expression Biochim Biophys Acta 1592 107 116 12379472 1:CAS:528:DC%2BD38XnvVOktrs%3D
29. UK Prospective Diabetes Study (UKPDS) Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 837 853 10.1016/S0140-6736(98)07019-6 (Pubitemid 28416718)
30. HC Gerstein ME Miller RP Byington, et al. 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559 18539917 10.1056/NEJMoa0802743 1:CAS:528:DC%2BD1cXnt1Wjs7s%3D (Pubitemid 351831356)
31. W Duckworth C Abraira T Moritz, et al. 2009 Glucose control and vascular complications in veterans with type 2 diabetes N Engl J Med 360 129 139 19092145 10.1056/NEJMoa0808431 1:CAS:528:DC%2BD1MXnsFWkug%3D%3D
32. JA Johnson SL Bowker 2010 Intensive glycaemic control and cancer risk in type 2 diabetes: a meta-analysis of major trials Diabetologia 54 25 31 20959956 10.1007/s00125-010-1933-3